Quantcast

Latest Radiopharmacology Stories

2014-06-18 08:28:33

DUBLIN, June 18, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/mm8w8l/medical_imaging) has announced the addition of the "Medical Imaging Reagents Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769A surge in the number of cancer and cardiovascular patients globally has prompted the growth of the medical imaging reagents market....

2014-06-17 12:29:56

ALBANY, New York, June 17, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Medical Imaging Reagents Market (Class: Contrast Reagents, Optical Reagents and Nuclear Reagents; Technology: Nanoparticles, Fluorescent Proteins, Fluorescent Dyes and Probes, Radiopharmaceuticals and Quantum Dots & Application: Diagnostics, Drug Discovery and Development and Research and Development) - Global Industry Analysis, Size, Share, Growth,...

2014-06-10 16:27:01

NEW YORK and LOS ANGELES, June 10, 2014 /PRNewswire/ -- NCM USA announced today it has signed a long-term clinical zirconium isotope ((89)Zr) supply and cGMP biologics labeling agreement with ImaginAb, Inc., an innovation leader in the use of biologics for imaging with Positron Emission Tomography (PET). The NCM radiopharmaceutical manufacturing footprint specializes in "next generation" cyclotron-generated PET isotopes, including (89)Zr, and incorporates advanced automation and...

2014-06-09 08:28:48

IBA to Manufacture and Supply 89Zr-Df-IAB2M for Multi-Center Studies in the US LOS ANGELES and DULLES, Va., June 9, 2014 /PRNewswire/ -- ImaginAb, Inc. (ImaginAb) and IBA Molecular North America, Inc. (IBA Molecular) announced that IBA Molecular has been selected to provide radiochemistry manufacturing and clinical distribution of (89)Zr-Df-IAB2M, an immunoPET tracer for imaging prostate cancer, to support multi-center clinical studies in the US. IBA Molecular will manufacture...

2014-06-05 08:28:20

KENNEWICK, Wash., June 5, 2014 /PRNewswire/ -- Advanced Medical Isotope Corporation ("AMIC") (OTCBB: ADMD), a late stage development company engaged primarily in the development of brachytherapy devices and medical isotopes for diagnostic and therapeutic applications, today announced that Dr. Darrell R. Fisher has been appointed to the AMIC Medical Advisory Board, joining Chairman Dr. Barry D. Pressman. http://photos.prnewswire.com/prnvar/20140115/CL46762LOGO Dr. Fisher is known...

2014-05-02 12:26:59

One-of-a-kind facility cost-effectively accelerates discovery and development timeline MATTAWAN, Mich., May 2, 2014 /PRNewswire/ -- MPI Research Chairman and CEO, William U. Parfet, Jack Hoppin, PhD, Co-Founder and Managing Partner of inviCRO, and Marc Berridge, PhD, President and Founder of 3D Imaging, today celebrated the grand opening of the new world-class Translational Imaging Center at the global headquarters of MPI Research in Mattawan, Mich. The facility is a one-of-a-kind...

2014-04-29 20:23:32

LONDON, April 29, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:The World Market for Cardiovascular Diagnosticshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/world_market_cardiovascular_diagnostics_1.htmlThis report provides the reader with an overview of the global cardiac diagnostics industry and the trends driving growth. Segments within the cardiac diagnostic market include:-- Electrocardiography including ECG testing, stress testing, Holter...

2014-04-29 12:32:37

SAINT-GENIS-POUILLY, France, April 29, 2014 /PRNewswire/ -- Advanced Accelerator Applications S.A. ("AAA" or "the Company"), an international specialist in Molecular Nuclear Medicine, today announced that Dr Kapil Dhingra has joined the Company Board of Directors as an Independent Non-Executive Director. Stefano Buono, Chief Executive Officer of AAA, commented: "Dr. Dhingra's guidance and perspective on clinical development, regulatory and commercial strategy will be...

2014-04-17 16:26:59

Lumiphore Inc., a pharmaceutical leader in bifunctional chelator design, is developing in vivo radio-diagnostic imaging and site-directed radio-therapeutics, using its proprietary bifunctional radionuclide metal-chelation technology; it has received a National Science Foundation Small Business Innovation Research (SBIR) Phase II Grant entitled "Novel macrocyclic chelating groups for use in targeted radioisotope diagnostic and companion diagnostic/therapeutic applications." BERKELEY,...

2014-04-15 12:30:12

Two-part webinar to highlight benefits of molecular imaging in drug development MATTAWAN, Mich., April 15, 2014 /PRNewswire/ -- MPI Research and Translational Imaging Center partners, inviCRO, and 3D Imaging, announce a complementary two-part webinar series that will examine the game-changing benefits of translational research approaches utilizing molecular imaging. Part I of the series, Bridging the Gap with Translational Imaging: Drug Development from Mouse to Man, kicks off on...


Word of the Day
holluschickie
  • A 'bachelor seal'; a young male seal which is prevented from mating by its herd's older males (mated bulls defending their territory).
This comes from the Russian word for 'bachelors.'
Related